Drug Profile
Staphylococcus epidermidis vaccine conjugate - Nabi
Alternative Names: Staphylococcus epidermidis (PS-1) vaccine conjugateLatest Information Update: 11 Jun 2008
Price :
$50
*
At a glance
- Originator Nabi Biopharmaceuticals
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Staphylococcal infections
Most Recent Events
- 11 Jun 2008 Discontinued - Phase-I for Staphylococcal infections in USA (unspecified route)
- 10 Feb 2006 Nabi Biopharmaceuticals has completed a phase I trial in Staphylococcal infections in USA
- 27 May 2005 Phase-I clinical trials in Staphylococcal infections in USA (unspecified route)